Search Filters

Search Results

Found 7 results

510(k) Data Aggregation

    K Number
    K211810
    Date Cleared
    2022-05-23

    (346 days)

    Product Code
    Regulation Number
    880.6250
    Reference & Predicate Devices
    Why did this record match?
    Device Name :

    Shamrock Powder Free Blue Nitrile Examination Gloves (Tested for use with Chemotherapy Drugs and Fentanyl

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    A patient examination glove is a disposable device intended for medical purpose that is worn on examiner's hand to prevent contamination between patient and examiner.

    These gloves were tested for use with Chemotherapy Drugs as per ASTM D6978-05(2019) Standard Practice for Assessment of Medical Gloves to Permeation by Chemotherapy Drugs and Fentanyl.

    Device Description

    Shamrock Powder Free Blue Nitrile Examination Gloves (Tested for use with Chemotherapy Drugs and Fentany) are non-sterile, single use, disposable gloves intended for medical purposes to be worn on the hands of examiners as a barrier protection to prevent contamination between a patient and an examiner. The qloves are powder free, ambidextrous, blue color, and beaded cuff.

    The gloves are designed and manufactured in accordance with the ASTM D6319-19 Standard Specification for Nitrile Examination Gloves for Medical Application.

    The gloves are also complied with requirements for Standard Practice for Assessment of resistance of Medical Gloves to Permeation by Chemotherapy Drugs and Fentanyl as per ASTM D6978-05 (Reapproved 2019).

    AI/ML Overview

    The document describes the acceptance criteria and performance of "Shamrock Powder Free Blue Nitrile Examination Gloves (Tested for use with Chemotherapy Drugs and Fentanyl)".

    Here's the breakdown of the requested information:

    1. Table of Acceptance Criteria and Reported Device Performance:

    Test NamePurposeAcceptance CriteriaReported Device Performance (Results)
    Biocompatibility
    ISO 10993-10: IrritationIrritation TestingPass/FailPass (Not a skin irritant)
    ISO 10993-10: SensitizationSensitization TestingPass/FailPass (Not a skin sensitizer)
    ISO 10993-5: CytotoxicityCytotoxicity TestingPass/FailFail (Exhibits severe cytotoxicity reactivity) - Note: This is acknowledged and addressed in the Summary of Non-Clinical Testing.
    ISO 10993-11: Systemic ToxicitySystemic Toxicity TestingPass/FailPass (Not toxic)
    Permeation Testing (ASTM D6978-05(2019))Assessment of resistance to permeation by chemotherapy drugs and FentanylMinimum breakthrough timesSee detailed table below for each chemical. The general criterion is to report breakthrough time.

    Detailed Permeation Testing Results:

    Chemotherapy Drug and ConcentrationReported Breakthrough Detection Time (Minutes)
    Carboplatin (Paraplatin), 10 mg/ml (10,000ppm)> 240 min
    Carmustine (BCNU), 3.3 mg/ml (3,300ppm)46.6 min
    Chloroquine 50mg/ml (50,000ppm)> 240 min
    Cisplatin, 1.0 mg/ml (1,000ppm)> 240 min
    Cyclophosphamide (Cytoxan), 20.0mg/ml (20,000 ppm)> 240 min
    Dacarbazine, 10.0mg/ml (10,000ppm)> 240 min
    Docetaxel, 10mg/ml (10,000ppm)> 240 min
    Doxorubicin HCI, 2.0mg/ml (2,000ppm)> 240 min
    Etoposide, 20.0mg/ml (20,000ppm)> 240 min
    Fluorouracil, 50.0mg/ml (50,000ppm)> 240 min
    Ifosfamide, 50 mg/ml (50,000 ppm)> 240 min
    Methotrexate, 25mg/ml (25,000 ppm)> 240 min
    Mitomycin C, 0.5 mg/ml (500 ppm)> 240 min
    Paclitaxel, 6.0 mg/ml (6,000 ppm)> 240 min
    Thiotepa, 10.0mg/ml (10,000ppm)64.8 min
    Vincristine Sulfate, 1 mg/ml (1,000 ppm)> 240 min
    Fentanyl Citrate Injection 100mcg/2ml (50mcg/1ml)> 240 min

    2. Sample size used for the test set and the data provenance:

    • Sample Size: Not explicitly stated in terms of number of gloves tested for each permeation or biocompatibility test. The document refers to compliance with standards like ASTM D6978-05(2019) and ISO 10993, which typically specify sample sizes for such tests.
    • Data Provenance: The testing was performed for the submitter, PT. Shamrock Manufacturing Corpora, based in North Sumatera, Indonesia. The tests are "non-clinical tests," implying laboratory-based testing rather than clinical data from human subjects.

    3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts (e.g. radiologist with 10 years of experience):

    • This information is not applicable as the document describes non-clinical testing of a medical device (gloves) for physical properties and chemical resistance. There is no "ground truth" established by human experts in the context of diagnostic performance or interpretation. The ground truth for these tests is defined by the standardized methodologies of ASTM and ISO.

    4. Adjudication method (e.g. 2+1, 3+1, none) for the test set:

    • This information is not applicable as the document describes non-clinical testing of a medical device (gloves). Adjudication methods are typically used in clinical studies involving human interpretation or subjective assessments, which are not relevant here.

    5. If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance:

    • This information is not applicable. The device is medical examination gloves, not an AI-powered diagnostic tool. Therefore, MRMC studies and AI assistance are irrelevant to this submission.

    6. If a standalone (i.e. algorithm only without human-in-the loop performance) was done:

    • This information is not applicable. The device is medical examination gloves, not an algorithm or software. The tests performed are laboratory-based assessments of material properties and chemical resistance.

    7. The type of ground truth used (expert consensus, pathology, outcomes data, etc):

    • The "ground truth" for this device's performance is established by standardized test methods and material science principles. For biocompatibility, it's defined by the pass/fail criteria of ISO 10993 standards. For permeation, it's the measured breakthrough time according to ASTM D6978-05(2019). These are objective, measurable criteria, not subjective expert consensus or clinical outcomes data.

    8. The sample size for the training set:

    • This information is not applicable. There is no "training set" in the context of device testing for medical gloves. This refers to a dataset used to train AI/machine learning models, which is irrelevant for this device.

    9. How the ground truth for the training set was established:

    • This information is not applicable for the same reasons as #8.
    Ask a Question

    Ask a specific question about this device

    Why did this record match?
    Device Name :

    Powder-Free Blue Nitrile Examination Gloves (Tested for use with Chemotherapy and Fentanyl) – Regular Cuff; Powder-Free
    Blue Nitrile Examination Gloves (Tested for use with Chemotherapy Drugs and Fentanyl) - Extended Cuff

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    A patient examination glove is a disposable device intended for medical purposes that is worn on the examiner's hand to prevent contamination between patient and examiner. These gloves were tested for use with Chemotherapy drugs and Fentanyl Citrate as per ASTM D6978-05 (Reapproved 2019) Standard Practice for Assessment of Medical Gloves of Permeation by Chemotherapy Drugs

    Device Description

    The Medline Powder-Free Blue Nitrile Examination Gloves (Tested for use with Chemotherapy Drugs and Fentanyl) – Regular Cuff and the Medline Powder-Free Blue Nitrile Examination Gloves (Tested for use with Chemotherapy Drugs and Fentany)) - Extended Cuff are non-sterile, single use, disposable gloves intended for medical purposes to be worn on the hands of examiners to prevent contamination between a patient and an examiner. The gloves are nitrile, powder-free, ambidextrous, and blue-colored with a beaded cuff. The proposed device is offered in two versions: Regular cuff (VS311) and Extended cuff (VS711).

    AI/ML Overview

    The provided document is a 510(k) Premarket Notification from Medline Industries, Inc. for their Powder-Free Blue Nitrile Examination Gloves. This document focuses on demonstrating the substantial equivalence of their new device to a legally marketed predicate device.

    It is NOT a study about a device employing an Artificial Intelligence (AI) algorithm. Therefore, the requested information regarding acceptance criteria and study proving device meets acceptance criteria for an AI device cannot be extracted directly from this document. The document describes traditional performance testing for physical attributes and chemical permeation resistance of medical gloves, not AI algorithm performance.

    However, I can extract and present analogous information from the document as if it were a "device" in a general sense, focusing on the acceptance criteria and performance data for the gloves as described. I will make a note where the requested information is not applicable (N/A) due to the nature of the device (medical gloves vs. AI algorithm).


    Acceptance Criteria and Device Performance for Medline Powder-Free Blue Nitrile Examination Gloves

    This document pertains to the performance testing of Medline Powder-Free Blue Nitrile Examination Gloves (Regular Cuff and Extended Cuff versions) for medical uses, specifically their resistance to chemotherapy drugs and Fentanyl permeation, as well as general physical characteristics. This is not an AI-powered device, so typical AI/ML study components like training/test sets, expert adjudication, or MRMC studies are not applicable.

    1. Table of Acceptance Criteria and Reported Device Performance

    The acceptance criteria for the gloves are based on various ASTM standards.

    Regular Cuff (VS311) - Summarized Performance

    CharacteristicAcceptance Criteria (Standard)Reported Device Performance (Average)Complies with Standard (Y/N)
    Biocompatibility
    Irritation TestingPass/Fail (Not a primary skin irritant)PassY
    Sensitization TestingPass/Fail (Not a primary skin sensitizer)PassY
    Cytotoxicity TestingPass/Fail (Not cytotoxic)Failed* (Device is cytotoxic)N*
    Systemic Toxicity TestingPass/Fail (Not toxic)PassY
    Physical Dimensions (per ASTM D6319-10)
    Glove Length (XS-XL)220mm min. (XS-S), 230mm min. (M-XL)247-251mmY
    Palm Width (XS-XL)Ranges from 70 ± 10mm (XS) to 120 ± 10mm (XL)78-119mm (within specified ranges)Y
    Finger Thickness (XS-XL)0.05mm min.0.15-0.16mmY
    Palm Thickness (XS-XL)0.05mm min.0.11mmY
    Freedom from Holes (per ASTM D5151-06 & ASTM D6319-10, G-1)AQL 1.5XS/Small/Medium – 1/200; Large – 4/400; X-Large -2/200Y
    Powder Content (per ASTM D6124-06)Less Than 2mg/glove0.16-0.20 mg/gloveY
    Chemotherapy Drug Permeation (per ASTM D6978-05)N/A (Breakthrough time specific to each drug)Varies per drug (>240 min for most, 33.1 min for Carmustine, 69.2 min for Thiotepa)Y (within stated limitations)
    Fentanyl Permeation (per ASTM D6978-05)N/A (Breakthrough time specific to Fentanyl)>240 minY

    *Note: The cytotoxicity testing failed, indicating the device is cytotoxic under the conditions of the study. However, the FDA has still cleared the device. This implies that the cytotoxicity is either not considered clinically significant for the intended use (external, short-term contact) or that the benefits outweigh this particular risk, likely due to a robust biocompatibility assessment involving multiple tests. This document itself doesn't elaborate further on the implications of the "Failed" cytotoxicity result beyond reporting it.

    Extended Cuff (VS711) - Summarized Performance (Only differences from Regular Cuff noted, otherwise assumed to be the same)

    CharacteristicAcceptance Criteria (Standard)Reported Device Performance (Average)Complies with Standard (Y/N)
    Physical Dimensions (per ASTM D6319-10)
    Glove Length (XS-XL)220mm min. (XS-S), 230mm min. (M-XL)298-302mm (Extended cuff, so longer than regular cuff)Y
    Palm Width (XS-XL)Ranges from 70 ± 10mm (XS) to 120 ± 10mm (XL)78-115mm (within specified ranges)Y
    Finger Thickness (XS-XL)0.05mm min.0.16-0.18mmY
    Palm Thickness (XS-XL)0.05mm min.0.12-0.23mmY
    Chemotherapy Drug Permeation (per ASTM D6978-05)N/AVaries per drug (>240 min for most, 59.4 min for Carmustine, 68.2 min for Thiotepa)Y (within stated limitations)
    Fentanyl Permeation (per ASTM D6978-05)N/A>240 minY

    2. Sample size used for the test set and the data provenance

    • Sample Size for Physical Dimensions and Powder Content: 13 glove samples of each size (extra-small, small, medium, large, and extra-large) were tested for physical dimensions. For powder content, the average results across all five sizes are summarized, implying individual testing for each size.
    • Sample Size for Freedom from Holes: Varies based on total number inspected:
      • Regular Cuff: XS/Small/Medium – 200 gloves each; Large – 400 gloves; X-Large -200 gloves.
      • Extended Cuff: XS/Small/Medium, Large, X-Large - 200 gloves each.
    • Sample Size for Permeation Testing: The document does not specify the exact number of samples tested for each chemotherapy drug or Fentanyl. The test method cited is ASTM D6978, which typically involves multiple replicates per drug.
    • Data Provenance: The tests were conducted to support a 510(k) premarket notification for a disposable medical device. This is regulatory testing to demonstrate compliance with recognized standards. The country of origin of the data is not explicitly stated beyond being part of an FDA submission. The nature of this engineering testing is retrospective, as it's data collected to support a product already manufactured or designed.

    3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts

    Not applicable. This is not an AI/ML device where expert human annotation typically establishes ground truth. The "ground truth" for glove performance is established by adherence to physical and chemical testing standards (e.g., ASTM D6319, ASTM D5151, ASTM D6124, ASTM D6978). The qualification of personnel conducting these lab tests would typically be laboratory technicians and engineers with expertise in the relevant standards and equipment, but this is not specified in the document.

    4. Adjudication method for the test set

    Not applicable. There is no human interpretative "test set" requiring adjudication in the context of this device. Performance is determined by objective physical and chemical measurements against defined standards.

    5. If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance

    Not applicable. This is not an AI-assisted device.

    6. If a standalone (i.e. algorithm only without human-in-the-loop performance) was done

    Not applicable. This is not an AI algorithm.

    7. The type of ground truth used

    The "ground truth" for the device's performance is objective measurement against established industry standards (ASTM standards for physical properties, hole detection, powder content, and chemical permeation). These standards define the acceptable range or threshold for each characteristic.

    8. The sample size for the training set

    Not applicable. This is not an AI/ML device and therefore does not have a "training set" in the context of machine learning.

    9. How the ground truth for the training set was established

    Not applicable. See point 8.

    Ask a Question

    Ask a specific question about this device

    K Number
    K182089
    Date Cleared
    2019-07-30

    (362 days)

    Product Code
    Regulation Number
    880.6250
    Reference & Predicate Devices
    N/A
    Why did this record match?
    Device Name :

    Powder Free Blue Nitrile Examination Gloves - Tested for Use with Chemotherapy Drugs

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    A Patient examination glove is a disposable device intended for medical purposes that worn on the examiner's hand or finger to prevent contamination between patient and examiner. Tested for use with chemotherapy drugs as listed below.

    Device Description

    Powder Free Blue Nitrite Examination Gloves- Tested for Use with Chemotherapy Drugs.

    AI/ML Overview

    This document describes the FDA's 510(k) clearance for "Powder Free Blue Nitrile Examination Gloves - Tested for Use with Chemotherapy Drugs" (K182089). The primary focus of the performance data in this document relates to the gloves' resistance to permeation by chemotherapy drugs.

    Here's an analysis based on your request, using the provided text:

    1. Table of Acceptance Criteria and Reported Device Performance:

    The "acceptance criteria" for gloves used with chemotherapy drugs are typically defined by regulatory bodies or consensus standards (like ASTM D6978, which is often referenced for chemotherapy glove testing) as a minimum breakthrough time. While explicit "acceptance criteria" values are not stated in this document as a separate column, the reported device performance clearly indicates whether the gloves meet the implied standard of extended protection (often >240 minutes for many drugs).

    Chemotherapy DrugConcentrationAcceptance Criteria (Implied by standard practice, e.g., ASTM D6978)Reported Device Performance (Breakthrough Detection Time)Meets Implied Criteria?
    Carmustine (BCNU)3.3 mg/mlTypically >240 min desired9.0 minNo (specifically cautioned against)
    Cisplatin1.0 mg/mlTypically >240 min desired>240 minYes
    Cyclophosphamide (Cytoxan)20mg/mlTypically >240 min desired>240 minYes
    Dacarbazine (DTIC)10.0 mg/mlTypically >240 min desired>240 minYes
    Doxorubicin Hydrochloride2.0mg/mlTypically >240 min desired>240 minYes
    Etoposide (Toposar)20.0 mg/mlTypically >240 min desired>240 minYes
    Fluorouracil50.0 mg/mlTypically >240 min desired>240 minYes
    Ifosfamide50.0 mg/mlTypically >240 min desired>240 minYes
    Methotrexate25 mg/mlTypically >240 min desired>240 minYes
    Mitomycin C0.5 mg/mlTypically >240 min desired>240 minYes
    Mitoxantrone2.0 mg/mlTypically >240 min desired>240 minYes
    Paclitaxel (Taxol)6.0 mg/mlTypically >240 min desired>240 minYes
    Thio-Tepa10.0 mg/mlTypically >240 min desired16.2 minNo (specifically cautioned against)
    Vincristine Sulfate1.0 mg/mlTypically >240 min desired>240 minYes

    Note: The document explicitly states: "Please Note that Carmustine and Thio-Tepa have low permeation time of less than 240 minutes. Do not use with Carmustine and Thio-Tepa." This indicates that for these two drugs, the gloves did not meet the standard expectation for chemotherapy glove use, and this limitation is clearly communicated.


    The subsequent questions (2-9) are primarily relevant to clinical studies involving AI or diagnostics that interpret medical data. This document describes the clearance of a medical device (gloves) based on laboratory testing for chemical permeation, not a clinical study involving human patients, expert readers, or AI algorithms. Therefore, most of these questions are not applicable to the provided information.

    However, I will address those that can be inferred or directly commented on:

    2. Sample size used for the test set and the data provenance:

    • Sample Size for Test Set: Not explicitly stated in terms of number of gloves tested, but it would involve multiple samples of the glove material subjected to permeation testing according to a standard like ASTM D6978. For each chemotherapy drug listed, a sample of the glove material would be exposed, and the time until breakthrough is detected would be measured.
    • Data Provenance: The document implies laboratory testing conducted by the manufacturer or a certified lab. The country of origin of the data is not specified beyond the manufacturer being "Platinum Glove Industries Sdn Bhd" from "Malaysia." This is retrospective testing of the glove material properties.

    3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts:

    • Not Applicable. This is not a study involving human interpretation of medical data where "ground truth" is established by experts. The "ground truth" in this context is the physical property of the glove's resistance to chemical permeation, measured by laboratory instrumentation and protocols (e.g., using a permeation cell and analytical detection methods).

    4. Adjudication method (e.g. 2+1, 3+1, none) for the test set:

    • Not Applicable. See point 3.

    5. If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance:

    • Not Applicable. This is not a clinical or AI-based diagnostic study.

    6. If a standalone (i.e. algorithm only without human-in-the loop performance) was done:

    • Not Applicable. This is not an algorithm.

    7. The type of ground truth used (expert consensus, pathology, outcomes data, etc):

    • The "ground truth" in this context is the measured chemical permeation time of specific chemotherapy drugs through the glove material, determined through standardized laboratory testing (e.g., in accordance with ASTM D6978 or an equivalent standard).

    8. The sample size for the training set:

    • Not Applicable. This is not an AI or machine learning study, so there is no "training set."

    9. How the ground truth for the training set was established:

    • Not Applicable. See point 8.
    Ask a Question

    Ask a specific question about this device

    K Number
    K181130
    Date Cleared
    2018-08-10

    (102 days)

    Product Code
    Regulation Number
    880.6250
    Reference & Predicate Devices
    Why did this record match?
    Device Name :

    Powder Free Blue Nitrile Examination Gloves, Tested for Use with Chemotherapy Drugs

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    The Powder Free Blue Nitrile Examination Gloves, Tested for Use with Chemotherapy Drugs is a disposable device intended for medical purposes that is worn on the examiner's hands to prevent contamination between patient and examiner.

    The proposed device was tested for use with Chemotherapy Drugs as per ASTM D6978-05 Standard Practice for Assessment of Medical Gloves to Permeation by Chemotherapy Drugs.

    Device Description

    The proposed device, Powder Free Blue Nitrile Examination Gloves, Tested for Use with Chemotherapy Drugs is a disposable device intended for medical purposes that is worn on the examiner's hands to prevent contamination between patient and examiner.

    The proposed device is a Powder Free Nitrile Patient Examination Glove that is available in multiple sizes

    The proposed device is provided non-sterile. The proposed device is made of Nitrile. The proposed device acts as a barrier.

    AI/ML Overview

    Here's a breakdown of the acceptance criteria and study information for the Powder Free Blue Nitrile Examination Gloves, Tested for Use with Chemotherapy Drugs, based on the provided FDA 510(k) submission.

    1. Table of Acceptance Criteria and Reported Device Performance

    The device is evaluated against specific ASTM standards for various properties and against a predicate device (K163146) for comparison. The key acceptance criteria and reported performance for critical aspects are as follows:

    Acceptance Criteria (Standard / Property)Specific Requirement (as per standard)Proposed Device PerformanceMet Criteria?
    Chemotherapy Drug PermeationBreakthrough Detection Time: > 240 minutes for most drugs, except where noted by predicateVaries per drug (see table below)Met for most, not for Carmustine and Thiotepa (but disclosed)
    Dimension (Length)>= 230 mm (min)230 mm (all sizes)Yes
    Dimension (Width)Varies per size (e.g., 70-120 mm) ±10Matches requirementYes
    Dimension (Thickness - Finger)0.07 mm ±0.02 (for proposed)0.07 mm ±0.02 (specified)Yes (meets own spec)
    Dimension (Thickness - Palm)0.05 mm (min, for proposed)0.05 mm (specified)Yes (meets own spec)
    Dimension (Thickness - Cuff)0.05 mm ±0.02 (for proposed)0.05 mm ±0.02 (specified)Yes (meets own spec)
    Tensile Strength (Before Aging)15 MPa, min (ASTM D6319)15 MPa, minYes
    Ultimate Elongation (Before Aging)500% min (ASTM D6319)500% minYes
    Tensile Strength (After Aging)14 MPa, min (ASTM D6319)14 MPa, minYes
    Ultimate Elongation (After Aging)400% min (ASTM D6319)400% minYes
    Detection of HolesNot detected (ASTM D5151)Not detectedYes
    Powder ContentMax. 0.35 mg per glove (specified for proposed, meets ASTM D6319)Max. 0.35 mg per gloveYes (meets own spec)
    Biocompatibility (Irritation)Not an irritant (ISO 10993-10)Not an irritantYes
    Biocompatibility (Sensitization)Not a sensitizer (ISO 10993-10)Not a sensitizerYes
    Biocompatibility (In Vitro Cytotoxicity)Not cytotoxic (ISO 10993-5)Not cytotoxicYes

    Chemotherapy Drug Permeation Performance and Acceptance Criteria (from tables on pages 2 and 5-6):

    The acceptance criterion for chemotherapy drug permeation is generally a breakthrough detection time of >240 minutes, as demonstrated by most drugs. However, for Carmustine and Thiotepa, lower breakthrough times are explicitly noted and acknowledged. The device performance for these drugs is compared against the general expectation and specific values are provided.

    Chemotherapy DrugConcentrationBreakthrough Detection Time in Minutes (Reported Device Performance)Acceptance Criteria Met? (Based on general >240 min, or specific disclosure for lower times)
    Bleomycin15 mg/ml (15,000 ppm)>240Yes
    Busulfan6 mg/ml (6,000 ppm)>240Yes
    Carboplatin10 mg/ml (10,000ppm)>240Yes
    Carmustine (BCNU)3.3 mg/ml (3,300ppm)8.5 (12.7, 13.4, 8.5) (Noted as having low permeation time)Yes (Disclosed and acceptable with warning)
    Cisplatin1.0 mg/ml (1,000ppm)>240Yes
    Cyclophosphamide(Cytoxan)20.0 mg/ml (20,000ppm)>240Yes
    Cytarabine100 mg/ml (100,000ppm)>240Yes
    Cytovene10 mg/ml (10,000ppm)>240Yes
    Dacarbazine(DTIC)10.0 mg/ml (10,000ppm)>240Yes
    Daunorubicin5 mg/ml (5,000ppm)>240Yes
    Docetaxel10.0 mg/ml(10,000 ppm)>240Yes
    Doxorubicin Hydrochloride2.0 mg/ml (2,000ppm)>240Yes
    Ellence2 mg/ml (2,000ppm)>240Yes
    Etoposide(Toposar)20.0 mg/ml(20,000ppm)>240Yes
    Fludarabine25 mg/ml(25,000ppm)>240Yes
    Fluorouracil50 mg/ml(50,000ppm)>240Yes
    Gemcitabine (Gemzar)38 mg/ml(38,000ppm)>240Yes
    Idarubicin1 mg/ml (1,000ppm)>240Yes
    Ifosfamide50.0 mg/ml (50,000ppm)>240Yes
    Irinotecan20.0 mg/ml (20,000ppm)>240Yes
    Mechlorethamine HCI1.0 mg/ml (1,000ppm)>240Yes
    Melphalan5 mg/ml (5,000ppm)>240Yes
    Methotrexate25mg/ml (25,000ppm)>240Yes
    Mitomycin C0.5 mg/ml (500 ppm)>240Yes
    Mitoxantrone2.0 mg/ml(2,000ppm)>240Yes
    Oxaliplatin2.0 mg/ml(2,000ppm)>240Yes
    Paclitaxel (Taxol)6.0 mg/ml(6,000ppm)>240Yes
    Rituximab10 mg/ml(10,000ppm)>240Yes
    Thiotepa10.0 mg/ml (10,000ppm)36.1 (51.2, 36.1, 45.6) (Noted as having low permeation time)Yes (Disclosed and acceptable with warning)
    Trisenox0.1 mg/ml (100ppm)>240Yes
    Vincristine Sulfate1.0 mg/ml (1,000ppm)>240Yes
    Vinorelbine10 mg/ml(10,000ppm)>240Yes

    2. Sample Size Used for the Test Set and Data Provenance

    The document does not explicitly state the exact sample size for each specific test. However, it indicates that "Bench tests were conducted to verify that the proposed device met all specifications."

    • Sample Size: Not explicitly stated as a numerical value for each test. The adherence to standards like ASTM D6319, ASTM D5151, ASTM D6124, ASTM D6978, ISO 2859-1, ISO 10993-10, and ISO 10993-5 implies that appropriate sample sizes, as dictated by these standards, were used for testing various properties (e.g., AQL for holes, specific number of samples for mechanical properties and chemical permeation). ISO 2859-1 specifically relates to "Sampling Procedures for Inspection by Attributes – Part I: Sampling Plans Indexed by Acceptable Quality Level (AQL) for Lot-by-Lot Inspection," indicating a quality control sampling approach for certain attributes.
    • Data Provenance: The tests were non-clinical bench tests conducted to evaluate the physical, performance, and biocompatibility characteristics of the gloves. The country of origin for the manufacturing company is China (Hebei Titans Hongsen Medical Technology Co., LTD.). The submission is for a medical device (gloves), and the testing appears to be prospective in nature, conducted specifically for this 510(k) submission to demonstrate compliance with standards.

    3. Number of Experts Used to Establish the Ground Truth for the Test Set and Qualifications of Those Experts

    This type of information is not applicable to this submission. The device is a medical glove, and its performance is evaluated against established physical, chemical, and biological standards (ASTM and ISO). The "ground truth" here is the pass/fail criteria defined by these objective engineering and material science standards, not subjective human interpretations or expert consensus on medical images or diagnoses.

    4. Adjudication Method for the Test Set

    This is not applicable as the evaluation is based on objective, standardized test methods with clear pass/fail criteria, not on subjective expert review requiring adjudication.

    5. If a Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study Was Done, and the Effect Size of How Much Human Readers Improve with AI vs. Without AI Assistance

    This is not applicable. This submission is for a medical device (gloves) and does not involve AI or human readers for diagnostic or interpretive tasks.

    6. If a Standalone (i.e., algorithm only without human-in-the-loop performance) Was Done

    This is not applicable. This submission is not for an algorithm or AI device.

    7. The Type of Ground Truth Used

    The "ground truth" in this context refers to the established scientific and engineering standards and their predefined pass/fail criteria. These include:

    • ASTM D6319-10: Standard Specification for Nitrile Examination Gloves for Medical Application (for dimensions, physical properties).
    • ASTM D5151-06: Standard Test Method for Detection of Holes in Medical Gloves.
    • ASTM D6124-06: Standard Test Method for Residual Powder on Medical Gloves.
    • ASTM D6978-05: Standard Practice for Assessment of Medical Gloves to Permeation by Chemotherapy Drugs (for chemical permeation).
    • ISO 2859-1:1999: Sampling Procedures for Inspection by Attributes – Part I: Sampling Plans Indexed by Acceptable Quality Level (AQL) for Lot-by-Lot Inspection.
    • ISO 10993-10: 2010: Biological evaluation of medical devices Part 10: Tests for irritation and skin sensitization.
    • ISO 10993-5:2009: Biological Evaluation of Medical Devices - Part 5: Tests For In Vitro Cytotoxicity.

    The performance values obtained from the actual testing of the gloves are compared directly against the quantitative limits set forth in these standards.

    8. The Sample Size for the Training Set

    This is not applicable. The device is a physical product (gloves) and does not involve a "training set" in the context of machine learning or AI models.

    9. How the Ground Truth for the Training Set Was Established

    This is not applicable for the same reason as point 8.

    Ask a Question

    Ask a specific question about this device

    K Number
    K172864
    Date Cleared
    2018-05-02

    (224 days)

    Product Code
    Regulation Number
    880.6250
    Reference & Predicate Devices
    Why did this record match?
    Device Name :

    Non-Sterile Powder Free Blue Nitrile Examination Gloves Tested for Use with Chemotherapy Drugs

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    A powder free nitrile examination glove is a disposable device intended for medical purposes that is worn on the examiner's hands and finger to prevent contamination between patient and examiner. In addition, these gloves were tested for use with chemotherapy drugs in accordance with ASTMD6978-05 Standard Practice for Assessment of Medical Gloves to Permeation by Chemotherapy Drugs:

    Device Description

    These patient examination gloves are formulated using nitrile, non-sterile, powder free, meet all the requirements of ASTM D6319 and tested for use with chemotherapy drugs.

    AI/ML Overview

    The provided text describes the acceptance criteria and performance of "Non-Sterile Powder Free Blue Nitrile Examination Gloves Tested for Use with Chemotherapy Drugs." This is a medical device, and the data presented relates to its physical and chemical properties, not an AI/ML powered device. Therefore, many of the requested fields are not applicable.

    Here's the information extracted from the document based on the prompt:

    1. A table of acceptance criteria and the reported device performance

    CharacteristicsStandardsAcceptance Criteria (Predicate)Reported Device Performance (Current)
    Manufacturer-Kossan International Sdn BhdMaxter Gloves Manufacturing Sdn Bhd
    510 (K) Number-K151750K172864
    DimensionsASTM D6319-10≥ 230mm≥ 230mm
    Physical PropertiesASTM D6319-10MeetMeet
    Thickness - Finger - PalmASTM D6319-10≥ 0.05mm≥ 0.05mm
    Freedom From HolesASTM D6319-10 and ASTM D5151PassPass
    Powder Free ResidueASTM D6319-10 and ASTM D6124MeetMeet
    Resistance to Permeation by Chemotherapy Drugs (ASTM D6978-05)
    Carmustine (BCNU) 3.3mg/mlConcentration10.1 minutes8.3 minutes
    Cisplatin 1.0mg/mlConcentration>240 minutes>240 minutes
    Cyclophosphamide (Cytoxan) 20mg/mlConcentration>240 minutes>240 minutes
    Cytarabine 100mg/mlConcentration>240 minutes>240 minutes
    Dacarbazine (DTIC) 10.0mg/mlConcentration>240 minutes>240 minutes
    Doxorubicin Hydrochloride 2.0mg/mlConcentration>240 minutes>240 minutes
    Etoposide (Toposar) 20.0mg/mlConcentration>240 minutes>240 minutes
    Fluorouracil 50.0 mg/mlConcentrationNot explicitly stated for Predicate in table, but indicated as >240 for Current device. Given the "similar to predicate" statement, it's reasonable to infer a similar acceptance criteria.>240 minutes
    Ifosfamide 50.0 mg/mlConcentration>240 minutes>240 minutes
    Methotrexate 25mg/mlConcentration>240 minutes>240 minutes
    Mitomycin C 0.5mg/mlConcentration>240 minutes>240 minutes
    Mitoxantrone 2.0mg/mlConcentration>240 minutes>240 minutes
    Paclitaxel (Taxol) 6.0mg/mlConcentration>240 minutes>240 minutes
    Thiotepa 10.0mg/mlConcentration30.2 minutes38.0 minutes
    Vincristine Sulfate 1.0mg/mlConcentration>240 minutes>240 minutes
    Warning Statement-Warning: Please note that the following drugs have extremely low permeation times: Carmustine(BCNU): 10.1 minutes and Thiotepa: 30.2 minutesWarning: Please note that the following drugs have low permeation time of less than 240 minutes: Carmustine (BCNU): 8.3 minutes and Thiotepa: 38.0 minutes. Do not use with Carmustine or Thiotepa.
    Biocompatibility: Primary Skin IrritationISO 10993Non-irritantNon-irritant
    Biocompatibility: Dermal SensitizationISO 10993Non-sensitizerNon-sensitizer
    Biocompatibility: In vitro CytotoxicityISO 10993Not available (for Predicate)The device extract was not cytotoxic.
    MaterialASTM D6319-10NitrileNitrile
    Color-Blue, and whiteBlue
    Texture-Finger TexturedFinger Textured
    SizeMedical Glove Guidance Manual-LabelingExtra Small, Small, Medium, Large, Extra LargeExtra Small, Small, Medium, Large, Extra Large
    Single UseMedical Glove Guidance Manual-LabelingSingle useSingle use

    2. Sample size used for the test set and the data provenance (e.g. country of origin of the data, retrospective or prospective)

    The document does not explicitly state the sample size for the tests conducted to determine the breakthrough detection times or other physical properties. It generally refers to conducting tests "in accordance with ASTMD6978-05 Standard Practice for Assessment of Medical Gloves to Permeation by Chemotherapy Drugs," and other ASTM and ISO standards. These standards typically specify sample sizes for their respective tests. The provenance of the data is implied to be from the manufacturer's testing (Maxter Glove Manufacturing Sdn Bhd) in Malaysia, as they are the submitter of the 510(k). The tests are prospective in nature, as they are performed to demonstrate compliance with standards for the device being submitted.

    3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts (e.g. radiologist with 10 years of experience)

    Not applicable. This is a physical device (gloves) and the "ground truth" is established through standardized laboratory testing against chemical permeation and physical properties, not through expert consensus on medical images or diagnoses.

    4. Adjudication method (e.g. 2+1, 3+1, none) for the test set

    Not applicable. This is a physical device.

    5. If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance

    Not applicable. This is a physical device, not an AI/ML powered medical device.

    6. If a standalone (i.e. algorithm only without human-in-the-loop performance) was done

    Not applicable. This is a physical device.

    7. The type of ground truth used (expert consensus, pathology, outcomes data, etc)

    The "ground truth" for this device is based on objective measurements conducted according to established international and national standards (e.g., ASTM D6319-10, ASTM D5151, ASTM D6124, ASTM D6978-05, ISO 10993). This involves laboratory measurements for physical dimensions, tensile strength, elongation, freedom from holes, powder residue levels, breakthrough time for chemotherapy drugs, and biocompatibility endpoints (irritation, sensitization, cytotoxicity).

    8. The sample size for the training set

    Not applicable. This is a physical device, not an AI/ML-powered device that requires a training set.

    9. How the ground truth for the training set was established

    Not applicable. This is a physical device.

    Ask a Question

    Ask a specific question about this device

    K Number
    K101822
    Manufacturer
    Date Cleared
    2010-11-19

    (142 days)

    Product Code
    Regulation Number
    880.6250
    Reference & Predicate Devices
    Why did this record match?
    Device Name :

    NON-STERILE POWDER-FREE BLUE NITRILE EXAMINATION GLOVES TESTED FOR USE WITH CHEMOTHERAPY DRUGS

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    A disposable medical glove to be worn on the hand of the healthcare and similar personnel to prevent contamination between healthcare personnel and patient.

    Device Description

    Non-sterile , Powder-free Blue Nitrile Examination Gloves , Tested for use with Chemotherapy Drugs.

    AI/ML Overview

    The provided documents describe the performance of "Non-sterile, Powder-free Blue Nitrile Examination Gloves, Tested for use with Chemotherapy Drugs" (K101822) against various acceptance criteria relevant to medical examination gloves and specifically for their resistance to chemotherapy drugs.

    Here’s a breakdown of the information requested:

    1. Table of Acceptance Criteria and Reported Device Performance

    The acceptance criteria for the device are largely based on established ASTM (American Society for Testing and Materials) standards and a comparison to a legally marketed predicate device (K082957). The key performance indicator for chemotherapy drug resistance is the "Breakthrough Detection Time" as per ASTM D6978-05.

    Acceptance Criteria and Reported Device Performance for K101822

    Characteristic and ParameterAcceptance CriteriaReported Device PerformanceMeets Criteria?
    General Glove Characteristics
    Device ClassClass I (as per predicate)Class IYes
    Product CodeLZA (as per predicate)LZAYes
    Glove ColorBlue (as per predicate)BlueYes
    DimensionsMeets ASTM D6319-00a-05Meets ASTM D6319-00a-05Yes
    Physical PropertiesMeets ASTM D6319-00a-05Meets ASTM D6319-00a-05Yes
    Freedom From PinholesMeets ASTM D6319-00a-05 (and/or ISO 2859-1, ASTM D5151-06)Meets ASTM D6319-00a-05Yes
    Powder-freeMeets ASTM D6124-06Meets ASTM D6124-06Yes
    Biocompatibility
    Primary Skin IrritationPasses Primary Skin Irritation in Rabbits (as per predicate)Passes Primary Skin Irritation in RabbitsYes
    SensitizationPasses Guinea Pig Maximization (similar to predicate's Guinea Pig Sensitization)Passes Guinea Pig MaximizationYes
    Chemotherapy Drugs Permeation (ASTM D6978-05)
    Cisplatin> 240 minutes (as per predicate)> 240 minutesYes
    Cyclophosphamide (Cytoxan)> 240 minutes (as per predicate)> 240 minutesYes
    Doxorubicin Hydrochloride> 240 minutes (as per predicate)> 240 minutesYes
    Etoposide (Toposar)> 240 minutes (as per predicate)> 240 minutesYes
    Flurouracil> 240 minutes (as per predicate)> 240 minutesYes
    Paclitaxel (Taxol)> 240 minutes (as per predicate)> 240 minutesYes
    Vincristine Sulfate> 240 minutes (as per predicate)> 240 minutesYes
    Dacarbazine (DTIC)> 240 minutes (as per predicate)> 240 minutesYes
    Methotrexate> 240 minutes (as per predicate)> 240 minutesYes
    Carmustine (BCNU)Not specified as a pass/fail threshold, but noted as having extremely low permeation time in the predicate0.49 minutesNo (Note: Not approved for use with this drug)
    ThiotepaNot specified as a pass/fail threshold, but noted as having extremely low permeation time in the predicate2.61 minutesNo (Note: Not approved for use with this drug)
    LabelingMeets FDA requirementMeets FDA requirementYes

    Summary of Study Proving Acceptance:

    The device K101822 was shown to meet its acceptance criteria through various tests described in the "Substantial Equivalence Discussion" (Document 2, page 2 of 2) and the "CONCLUSION" (Document 4, page 1 of 1). The primary study for chemotherapy drug resistance was conducted according to ASTM D6978-05. For other characteristics like dimensions, physical properties, freedom from pinholes, and powder-free status, the device was tested against and found to meet ASTM D6319-00a-05, ISO 2859-1 (for water leak test), ASTM D5151-06 (for detection of holes), and ASTM D6124-06 respectively. Biocompatibility tests included Primary Skin Irritation in Rabbits and Guinea Pig Maximization tests.

    The device's performance was directly compared to a legally marketed predicate device, Siam Sempermed Corp. Ltd.'s Non-sterile, Powder-free Nitrile Examination Glove (K082957), showing substantial equivalence in all tested parameters, except for highlighting the short permeation times for Carmustine (BCNU) and Thiotepa, for which the gloves are explicitly not approved.

    2. Sample size used for the test set and the data provenance

    • Sample Size for Test Set: The specific sample sizes for each test (e.g., number of gloves tested for chemotherapy permeation, number of rabbits/guinea pigs for biocompatibility, or specific counts for physical properties) are not explicitly stated in the provided documents. The documents only state that the device "Meets ASTM D6319-00a-05," "Meets ASTM D6124-06", etc., which implies that the testing was performed according to the methodologies and sample size requirements specified in those respective ASTM/ISO standards.
    • Data Provenance: The data is presented as part of a 510(k) Premarket Notification submission to the FDA by SGMP Company Limited, located in Thailand (Document 0, page 1 of 2). This indicates the testing was conducted by or on behalf of the manufacturer, and generally, such data would be generated in a controlled laboratory environment. The documents do not specify the country of origin of the specific lab that conducted these tests, but the manufacturer is based in Thailand. The studies were retrospective in the sense that they were conducted to characterize the finished medical device for regulatory submission, rather than as part of a clinical trial.

    3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts

    This question is not applicable to this type of device submission. The "ground truth" for the performance of these examination gloves is established through standardized laboratory tests (e.g., ASTM standards) measuring physical and chemical properties, not through expert human interpretation or clinical ground truth. Therefore, there are no "experts" in the sense of medical professionals establishing ground truth for diagnostic accuracy, nor are their qualifications relevant here.

    4. Adjudication method for the test set

    This question is not applicable. Adjudication methods (like 2+1, 3+1) are typically used in clinical studies or studies involving human judgment (e.g., for image interpretation) to resolve disagreements among experts. The performance of these gloves is determined by objective, quantitative laboratory measurements according to published standards.

    5. If a multi-reader multi-case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance

    This question is not applicable. An MRMC study is relevant for diagnostic devices (e.g., AI algorithms for image interpretation) where human readers evaluate cases with and without AI assistance. This submission describes an examination glove, which is a physical barrier device, and does not involve human readers or AI assistance.

    6. If a standalone (i.e., algorithm only without human-in-the-loop performance) was done

    This question is not applicable. This describes a physical medical device (examination gloves), not an algorithm or AI system.

    7. The type of ground truth used

    The ground truth used for performance validation is based on objective, quantitative measurements obtained through standardized laboratory testing protocols, primarily from ASTM standards (D6319-00a-05, D6124-06, D6978-05) and ISO 2859-1. For biocompatibility, the ground truth is established by the observed biological responses in animal models (rabbits and guinea pigs) according to standardized tests for skin irritation and sensitization. The device's performance is then compared against the requirements specified in these standards and against the performance of a legally marketed predicate device.

    8. The sample size for the training set

    This question is not applicable. This is a physical medical device, not an AI model or algorithm that requires a "training set" of data.

    9. How the ground truth for the training set was established

    This question is not applicable as there is no training set for this type of device.

    Ask a Question

    Ask a specific question about this device

    K Number
    K051378
    Manufacturer
    Date Cleared
    2005-08-03

    (69 days)

    Product Code
    Regulation Number
    880.6250
    Reference & Predicate Devices
    N/A
    Why did this record match?
    Device Name :

    POWDER-FREE BLUE NITRILE EXAMINATION GLOVES (TESTED FOR USE WITH CHEMOTHERAPY DRUGS)

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    Medline Powder-Free Blue Nitrile Examination Gloves (Tested for Use with Chemotherapy Drugs) is a disposable device intended for medical purposes that is worn on the examiner's hand or finger to prevent contamination between patient and examiner.

    Device Description

    Medline Powder-Free Blue Nitrile Examination Gloves (Tested for use with Chemotheraphy Drugs)

    AI/ML Overview

    This document is a 510(k) clearance letter from the FDA for Medline Powder-Free Blue Nitrile Examination Gloves. It primarily addresses regulatory approval and does not contain information about studies proving the device meets acceptance criteria related to its performance beyond its intended medical purpose. The letter confirms the device is substantially equivalent to legally marketed predicate devices, but it does not include performance data, study designs, or details on ground truth establishment that would typically be found in a clinical study report or technical documentation for device performance.

    Therefore, I cannot extract the requested information regarding acceptance criteria and performance studies from the provided text.

    Ask a Question

    Ask a specific question about this device

    Page 1 of 1